Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE) · FederalPipeline
Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
Special Notice from National Institutes of Health, solicitation ARPA-H-SN-25-131. Responses due Oct 2, 2025. NAICS 541714, No Set aside used. Listed on SAM.gov.